Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model

European Journal of Heart Failure

Volumn 11, Issue 4, 2009, Pages 342-348

  Lenk, Karsten ^a   Schur, Robert ^a   Linke, Axel ^a   Erbs, Sandra ^a   Matsumoto, Yasuharu ^a   Adams, Volker ^a   Schuler, Gerhard ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Chronic heart failure; Exercise training; Heart muscle; Myostatin; Skeletal muscle; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOSTATIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; EXPERIMENTAL MODEL; GENE EXPRESSION; HEART FAILURE; HEART MUSCLE; KINESIOTHERAPY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; TREADMILL EXERCISE;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXERCISE THERAPY; GENE EXPRESSION; HEART FAILURE; MUSCLE, SKELETAL; MYOCARDIUM; MYOSTATIN; RATS; RATS, INBRED WKY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 66249091925     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp020     Document Type: Article

References (35)

1. Katz SD, Rao R, Berman JW, Schwarz M, Demopoulos L, Bijou R, LeJemtel TH. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodila-tion in the forearm circulation. Circulation 1994;90:12-16.
2. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996;93:704-711.
3. Gielen S, Adams V, Möbius-Winkler S, Linke A, Erbs S, Yu J, Kempf W, Schubert A, Schuler G, Hambrecht R. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 2003;42:861-868.
4. Anker SD, Coats AJ. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 1999;115:836-847.
5. Gupta S, Tripathi CD. Current status of TNF blocking therapy in heart failure. Indian J Med Sci 2005;59:363-366.
6. Carlson CJ, Booth FW, Gordon SE. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol 1999; 277:R601-R606.
7. Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, Arias J, Salehian B. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 2003; 285:E363-E371.
8. Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, Sinha-Hikim I, Ma K, Ezzat S, Shen R, Lalani R, Asa S, Mamita M, Nair G, Arver S, Bhasin S. Organization of the human myostatin gene and expression in healthy men and HIV infected men with muscle wasting. Proc Natl Acad Sci USA 1998;95:14938-14943.
9. Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM, Lee SJ. Induction of cachexia in mice by systemically administered myostatin. Science 2002;296:1486-1488.
10. McPherron AC, Lawler AM, Lee S-J. Regulation of skeletal muscle mass in mice by a newTGF-beta superfamily member. Nature 1997;387:83-90.
11. Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, Conaglen JV, Fowke PJ, Bass JJ. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct.J Cell Physiol 1999;180:1-9.
12. Cook SA, Matsui T, Li L, Bosenzweig A. Transcriptional effects of chronic Akt activation in the heart. J Biol Chem 2002;277:22528-22533.
13. Shyu KG, Lu MJ, Wang BW, Sun HY, Chang H. Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure. Eur J Clin Invest 2006; 36:713-719.
14. Kim JS, Cross JM, Bamman MM. Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women. Am J Physiol 2005;288:E1110-E1119.
15. Walker KS, Kambadur R, Sharma M, Smith HK. Resistance training alters plasma myostatin but not IGF-1 in healthy men. Med Sci Sports Exerc 2004;36:787-793.
16. Willoughby DS. Effects of heavy resistance training on myostatin mRNA and protein expression. Med Sci Sports Exerc 2004;36:574-582.
17. Matsakas A, Friedel A, Hertrampf T, Diel P. Short-term endurance training results in a muscle-specific decrease of myostatin mRNA content in the rat muscle. Acta Physiol Scand 2005;183:299-307.
18. Matsakas A, Bozzo C, Cacciani N, Caliaro F, Reggiani C, Mascarello F, Patruno M. Effect of swimming on myostatin expression in white and red gastrocnemius muscle and in cardiac muscle of rats. Exp Physiol 2006;91:983-994.
19. 2+ sensitivity and SERCA-2 in rat after myocardial infarction. Cardiovasc Res 2002;54:162-174.
20. Dimmeler S, Assmus B, Hermann C, HaendelerJA, Zeiher AM. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells. Circ Res 1998;83:334-341.
21. Adams V, Linke A, Kränkel N, Erbs S, Gielen S, Möbius-Winkler S, Gummert JF, Mohr FW, Schuler G, Hambrecht R. Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation 2005;111:555-562.
22. Linke A, Adams V, Schulze PC, Erbs S, Gielen S, Fiehn E, Möbius-Winkler S, Schubert A, Schuler G, Hambrecht R. Antioxidative effects of exercise training in patients with chronic heart failure. Increase in radical scavenger enzyme activity in skeletal muscle. Circulation 2005;111:1763-1770.
23. Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL, Griswold DE. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 1996;279:1453-1461.
24. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo.J Biol Chem 1995;270:27489-27494.
25. Kleinert H, Euchenhofer C, Ihrig-Biedert I, Förstermann U. In murine 3T3 fibro-blasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-KB. J Biol Chem 1996;271:6039-6044.
26. Adams V, Linke A, Gielen S, Erbs S, Hambrecht R, Schuler G. Modulation of Murf-1 and MAFbx expression in the myocardium by physical exercise training. EurJ Cardiovasc Prev Rehabil 2008;15:293-299.
27. Torre-Amione G, Kapadia SR, Benedict C, Oral H, YoungJB, Mann DL. Proinflam-matory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996;27:1201-1206.
28. Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman JW, LeJemtel TH. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996;28:964-971.
29. Lommi J, Koskinen P, Näveri H, Leinonen H, Härkönen M, Kupari M. Haemo-dynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. Eur Heart J 1997;18:1620-1625.
30. Anker SD, Clark AL, Kemp M, Salsbury C, Teixeira MM, Hellewell PG, Coats AJ. Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol 1997;30:997-1001.
31. Monsuez JJ, Escaut L, Teicher E, Charniot JC, Vittecoq D. Cytokines in HIV-associated cardiomyopathy. Int J Cardiol 2007;120:150-157.
32. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004;287:C834-C843.
33. Bakkar N, Wackerhage H, Guttridge DC. Myostatin and NF-κB Regulate Skeletal Myogenesis Through Distinct Signaling Pathways. Signal Transduct 2005;5:202-210.
34. Wagner KR. Muscle regeneration through myostatin inhibition. Curr Opin Rheumatol 2005;17:720-724.
35. Forbes D, Jackman M, Bishop A, Thomas M, Kambadur R, Sharma M. Myostatin auto-regulates its expression by feedback loop through Smad7 dependent mechanism. J Cell Physiol 2006;206:264-272.